Clinical Trials & Research
Oftentimes, when people think about medical research and clinical trials, they believe that the most advanced trials are only accessible at hospital organizations. This is not true! Child Neurology & Consultants of Austin is at the forefront of pediatric neurosciences research — making available new medicines and technologies to patients via clinical trials.
All clinical trial participation is optional for patients and is not required for clinical care. If you have questions about joining a study, please speak to your child’s physician or contact our clinical coordinator. Additional studies may be available soon.
Research Study Listing
Description |
Focus |
||
|---|---|---|---|
| An Open-Label Study With an Extension Phase to Evaluate the Pharmacokinetics of Perampanel Oral Suspension When Given as an Adjunctive Therapy in Subjects From 1 Month to Less Than 24 Months (<2 years) of Age with Epilepsy Primary Investigator: Karen Keough, MD Status: Closed |
Epilepsy | Request Info | |
| Comprehensive Outcomes Registry in Subjects with Epilepsy Treated with Vagus Nerve Stimulation Therapy Primary Investigator: Karen Keough, MD Status: Closed |
Epilepsy | Request Info | |
| An Open-Label Study with Extension Phase to Evaluate the Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Subjects (Age 1 Month to less than 18 Years) with Childhood Epilepsy in Subjects From 1 Month to Less Than 24 Months (<2 years) of Age with Epilepsy Primary Investigator: Karen Keough, MD Status: Open |
Epilepsy | More information | Request Info |
| An Observational Registry of Abatacept in Patients with Juvenile Idiopathic Arthritis Primary Investigator: Ruy Carrasco, MD Status: Open |
JIA | Request Info | |
| A 20-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in Patients with Dravet Syndrome (ARGUS Trial) Primary Investigator: Karen Keough, MD Status: Open |
Dravet Syndrome | More information | Request Info |
| A Phase 3, Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy Primary Investigator: Karen Keough, MD Status: Open |
Tuberous Sclerosis Complex-Related Epilepsy | More information | Request Info |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Examine The Efficacy And Safety Of ZX008 In Subjects With CDKL5 Deficiency Disorder Followed By An Open-Label Extension Primary Investigator: Karen Keough, MD Status: Open |
CDKL5 Deficiency Disorder | More information | Request Info |
| Phase 3, Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of Rimegepant for the Acute Treatment of Migraine (With or Without Aura) in Children and Adolescents ≥ 6 to <18 Years of Age. Primary Investigator: Katherine Labiner, MD Status: Open |
Acute Treatment of Migraine | More information | Request Info |
| Phase 3, Multicenter, Randomized, Double-blind, Group Sequential, Placebo-controlled Study to Assess Efficacy and Safety of Rimegepant or the Treatment of Migraine (With or Without Aura) in Children and Adolescents ≥ 6 to <18 Years of Age Primary Investigator: Katherine Labiner, MD Status: Open |
Acute Treatment of Migraine | More information | Request Info |
| A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Cenobamate Adjunctive Therapy in Subjects With PGTC Seizures Primary Investigator: Karen Keough, MD Status: Open |
Primary Generalized Epilepsy | More information | Request Info |
To find out more about our clinical trials, email Child Neurology & Consultants of Austin’s research coordinator, Victoria Henderson, at victoria.henderson@pediatrix.com.
